1. |
Luetscher Jr JA, Deming QB, Harvey J, et al. Treatment of nephrosis with cortisone[J]. J Clin Invest, 1950, 29(12): 1576-1587.
|
2. |
Vanderwoude FJ. Mycophenplate mofetil(RS 61443): nothing new under the sun or an important break-through in the field of transplantation? [J]. Nephrol Dial Transpl, 1995, 10(7): 1112-1115.
|
3. |
Huang YF, Liu ZH, Huang HD, et al. Effects of mycophenolic acid on endothelial cells[J]. Int Immunopharmacol, 2005, 5(6): 1029-1039.
|
4. |
Allison AC. Mechanisms of action of mycophenolate mofetil[J]. Lupus, 2005, 14(3): S2-S8.
|
5. |
Apple GB, Radhakrishnan J, Ginzler EM. Use of mycophenolate mofetil in autoimmune and renal diseases[J]. Transplantation, 2005, 80(2): S265-S271.
|
6. |
Mase BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study[J]. Kidney Int, 2004, 65(5): 1842-1849.
|
7. |
Trinidad PR, Meza L, Diaz OA. Mycophenolate mofetil treatment in primary glomerular diseases without response to conventional immunosuppressive agents[J]. J Am Soc Nephrol, 2003, 14(7): 800-812.
|
8. |
Polenakovic M, Grcevska L, Dzikova S. Mycophenolate mofetil in treatment of idiopathic stages IIII-V membranous nephropathy[J]. Nephrol Dial Transpl, 2003, 18(6): 1233-1234.
|
9. |
D’Amcio G. Natural history of idiopathic IgA nephropathy: the role of clinical and histological prognostic factors[J]. Am J Kidney Dis, 2002, 36(2): 227-37.
|
10. |
Tang S, Tang A, Wong S, et al. Long–term study of mycophenolate mofetil treatment in IgA nephropathy[J]. Kidney Int, 2010, 77(6): 543-549.
|
11. |
Groth C, Pichlmayr R, Sadek S, et al. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection[J]. Lancet, 1995, 345(8961): 1321-1325.
|
12. |
Appel GB, Contreras G, Dooley MA, et al. mycophenolate mofetil versus cyclophosphamide for Induction Treatment of Lupus Nephritis[J]. J Am Soc Nephrol, 2009, 20(5): 1103-1112.
|
13. |
陈香美, 陈仆, 蔡广研, 等. 麦考酚酸酯治疗IgA 肾病的随访对照观察[J]. 中华医学杂志, 2006, 82(12): 796-891.
|
14. |
Donadio J, Grande J. IgA nephropathy[J]. N Engl J Med, 2002, 347(10): 738-748.
|
15. |
Galla JH. IgA nephropathy[J]. Kidney Int, 1995, 47(2): 377-387.
|
16. |
Zatz R, Noronha IL, Fujihara CK. Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies[J]. Am J Physiol Renal Physiol, 2002, 283(6): 1167-1175.
|
17. |
Russo D, Pisani A, Balletta MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and Losartan in normotensive patients with IgA nephropathy[J]. Am J Kidney Dis, 1999, 33(5): 851-856.
|
18. |
Samuels JA, Strippoli G FM, Craig J C, et al. Immunosuppressive agents for treating IGA nephropathy(Cochrane Review)[J]. Cochrane Database Syst Rev, 2003, (4): CD003965.
|
19. |
Bennett WM, Walke RG, Kincaid-Smith P. Treatment of IgA nephropathy with eicosapentanoic acid: A two-year prospective trial[J]. Clin Nephrol, 1989, 31(3): 128-131.
|
20. |
Pettersson EE, Rekola S, Berglund L, et al. Treatment of IgA nephropathy with omega-3 polysaturated fatty acids: a prospective, double-blind, randomised study[J]. Clin Nephrol, 1994, 41(4): 183-190.
|
21. |
Donadio JV Jr, Bergstralh EF, Offord KP, et al. A controlled trial of fish oil in IgA nephropathy[J]. N Engl J Med, 1994, 331(18): 1194-1199.
|
22. |
Donadio JV Jr, Larson TS, Bergstralh EJ, et al. A randomised trial of high dose compared with low dose omega-3 fatty acids in severe IgA nephropathy[J]. J Am Soc Nephrol, 2001, 12(4): 791-799.
|
23. |
Dillon JJ. Fish oil therapy for IgA nephropathy. Efficacy and interstudy variability[J]. J Am Soc Nephrol, 1997, 8(11): 1739-1744.
|
24. |
Nowack R, Birck R, Van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy[J]. The Lancet, 1997, 349(9054): 774.
|
25. |
Frisch G, Lin J L, Rosenstock J, et al. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial[J]. Nephrol Dial Transplant, 2005, 20(10): 2139-2145.
|
26. |
Tang S, Leung JC, Chan LY, et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy[J]. Kidney Int, 2005, 68(2): 802-812.
|
27. |
王伟铭. KDIGO关于原发性肾小球肾炎的治疗初步意见[J]. 中国医学前沿杂志, 2011, 3(2): 18-21.
|
28. |
Briggs WA, Choi MJ, Scheel PJ Jr. Successful mycophenolate mofetil treatment of glomerular disease[J]. Am J Kidney Dis, l998, 31(2): 2l3-217.
|
29. |
Borrows R, Chusney G, James A, et al. Determinants of mycophenolic acid levels after renal transplantation[J]. Ther Drug Monit, 2005, 27(4): 442-450.
|
30. |
Staatz CE, Tett SE, Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients[J]. Clin Pharmacokinet, 2007, 46(1): 13-58.
|
31. |
Hesselink DA, van Hest RM, Mathot R, et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein2[J]. Am J Transplant, 2005, 5(5): 987-994.
|
32. |
Lightstone L. Lupus nephritis: where are we now?[J]. Curr Opin Rheumatol, 2010, 22(3): 252-256.
|
33. |
Yu ZC, Zhou PJ, Xu D, et al. Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients[J]. Brit J Clin Pharmaco, 2006, 62(4): 446-452.
|
34. |
Zhou PJ, Xu D, Yu ZC, et al. Pharmacokinetics of mycophenolic acid and estimation of exposure using multiple linear regression equations in Chinese renal allograft recipients[J]. Clin Pharmacokinet, 2007, 46(5): 389-401.
|
35. |
Lu XY, Huang HF, Sheng TJ, et al. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients[J]. J Zhejiang Univ Sci B, 2005, 6 (9): 885-891.
|
36. |
Zheng CX, Liu ZH, Qin WS, et al. Moitoring of mycophenolic acid concentration for mycophenolate mofetil treatment in patients with glomerular diseases[J]. Chin Nephrol Dial Transplant, 2007, 16(5): 406-412.
|
37. |
Van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation[J]. Transplantation, 1999, 68(2): 261-266.
|